I
nterleukin-2 and IL-15 are structurally related cytokines with growth factor activity for T cells, B cells, NK cells, and NKT cells (1) (2) (3) . Both cytokines belong to the four-helix bundle family of proteins and bind to receptors with shared signaling components, but they differ in their cellular sites of synthesis and in their regulation of expression. IL-2 is produced by activated T cells and binds to a heterotrimeric receptor (IL-2R) consisting of the IL-2R ␣-, ␤-, and ␥-chains. In contrast, IL-15 is produced by many cell types in most tissues and binds to two different receptor complexes: on lymphocytes a trimeric receptor (IL-15R) consisting of the IL-15R ␣-chain and the ␤-and ␥-chains shared by IL-2R (1, 3, 4) , and on mast cells a distinct receptor, IL-15RX (5) . Studies in vivo and in vitro have demonstrated overlapping functions as well as distinct roles for IL-2 and IL-15 in lymphocyte development, homing, proliferation, and survival. Comparative studies of knockout mice deficient in IL-2R␣, IL-15R␣, IL-2/15R␤, IL-2, and IL-15 have demonstrated that IL-15/IL-15R signaling, but not IL-2/IL-2R signaling, is required for the development and homing of NK cells, NKT cells, and subsets of CD8 ϩ T cells, ␥␦ T cells, and intestinal intraepithelial lymphocytes (IELs) 3 (6 -11) . IL-2 and IL-15 added in vitro promote the survival and proliferation of memory lymphocytes (1, 10, 12) and the induction of cytolytic effector cells (13) , but while IL-2 predisposes activated T cells to die by apoptosis, IL-15 promotes their survival (14) . Exogenous IL-15 most notably induces the proliferation, survival, and effector functions of resting NK cells (13, 15, 16) , NKT cells (9) , ␥␦ T cells (17, 18) , and IELs (18 -20) , suggesting that it has a more general role in the activation of innate and tissue-associated immune responses.
In humans local immune responses are thought to be mediated in part by NK cells, ␥␦ T cells, and T cells that express activating receptors that are typically found on NK cells (21) (22) (23) (24) (25) . IL-2 and IL-15 can stimulate or augment human NK cell (13, 15, 16) and ␥␦ T cell (17) activation, but little is known about their effects on human NK receptor-positive (NKR ϩ ) T cells. Human NKR ϩ T cells are predominantly CD8 ϩ , they express ␣␤ or ␥␦ TCRs and activated/memory CD28 Ϫ CD45RA Ϫ CD45RO ϩ CD69 ϩ T cell phenotypes and possess a variety of NKRs, including CD16, CD56, CD161 (NKR-P1A), NKG2D, and receptors for MHC class I molecules (killer Ig-like receptors, KIRs), such as CD158a, CD158b, and KIR3DL1, and CD94) (22, 24, 26 -32) . Of these, CD56 ϩ T cells have been most extensively characterized with regard to phenotype and function. CD56 ϩ T cells can be induced to lyse NK-sensitive target cell lines in vitro (26, 27, 33) , and their activities are regulated by inhibitory KIR and CD94 molecules (22, 31) . CD56 ϩ T cells can also be activated by TCR ligation or in response to cytokines in the microenvironment and stress-inducible proteins present on target cells (33) (34) (35) . A small proportion (Ͻ1%) of peripheral CD56 ϩ T cells express an invariant V␣24J␣Q TCR ␣-chain that preferentially pairs with a V␤11 ␤-chain and recognizes glycolipid Ags presented by CD1d (32, 36) . Upon activation, CD56 ϩ T cells can rapidly produce proinflammatory (Th1-type) and Th2-type cytokines, suggesting roles for these cells both in innate immunity and in the regulation of adaptive immune responses (33, 37, 38) . CD56 ϩ T cells account for a small percentage (ϳ5%) of PBL, but they can expand rapidly in response to various stimuli (22, 24, 34) . They are also present in remarkably high numbers in the liver and bone marrow of healthy adults, accounting for 15-55% of all T cells in these organs (24, 32, 33) . The factors responsible for the selective accumulation of CD56 ϩ T cells at particular locations are unknown, but are likely to involve chemokines that preferentially recruit these cells from the circulation (39) and/or cytokines and that induce their local expansion (34) . Although IL-15 stimulates the growth of murine NKT cells (9) , little is known about its influence on the development and function of resting human NKR ϩ T cell subsets. Therefore, we have examined the relative effects of this cytokine on the proliferation, cytotoxic function, and cytokine secretion profiles of human lymphocyte subpopulations in the absence of stimulation and compared these effects with those of IL-2. 
Materials and Methods

Reagents
Human rIL-15 was purchased from R&D Systems (Abingdon, U.K.). Human rIL-2, BSA, sodium azide, PMA, ionomycin, saponin, and brefeldin A were purchased from Sigma (Poole, U.K.). CFSE was purchased from Molecular Probes (Leiden, The Netherlands).
Cells
PBMC were prepared from 15 healthy adults by Lymphoprep density gradient centrifugation (Nycomed, Oslo, Norway). Cells were cultured for 1-7 days in complete RPMI medium (RPMI 1640 containing 25 mM HEPES, 2 mM L-glutamine, 50 g/ml streptomycin, 50 U/ml penicillin, and 10% heat-inactivated FCS; Life Technologies, Paisley, U.K.) in the presence or the absence of the indicated amounts of human rIL-15 or IL-2. Cells were then analyzed phenotypically and in functional assays.
Abs and flow cytometry
Monoclonal Abs specific for CD3, CD4, CD8␣, CD16, CD56, CD161, CD158a, KIR3DL1, ␣␤TCR, ␥␦TCR, IFN-␥, TNF-␣, and IL-2 conjugated with FITC; anti-CD56, -CD4, -CD8␣, -CD25, and -CD122 conjugated with PE; anti-CD3, -CD8␣, -CD45, and -CD19 conjugated with PerCP; and isotype-matched anti-IgG controls (FITC, PE, and PerCP) were purchased from BD Biosciences (Oxford, U.K.). Unconjugated anti-CD3 (clone HIT3a) and anti-IL-4 FITC were obtained from BD PharMingen (Oxford, U.K.). Anti-V␣24 TCR biotin, anti-V␤11 PE, and unconjugated anti-CD94 and anti-CD8␤ were obtained from Coulter-Immunotech (Marseilles, France). The CD158b mAb was provided by Dr. L. Moretta (Instituto Nazionale per la Ricerca Sul Cancro Genova, Italy). Phenotypic analysis of lymphocyte subsets was performed by mAb staining and flow cytometry using a FACScan (BD Biosciences, Mountain View, CA) and analysis using CellQuest software (BD Biosciences) (32, 33) . Four-color flow cytometry was performed on a FACStar (BD Biosciences) with Multimate software (BD Biosciences).
Assessment of cell expansions
Cell numbers were determined before and after culture in the presence or the absence of IL-2 or IL-15 by staining with ethidium bromide and acridine orange and quantification of viable mononuclear cells (MNC) by fluorescent microscopy. The proportions of MNC that were positive for combinations of CD3, CD4, CD8␣, CD8␤, CD16, CD19, CD56, CD158a, CD158b, CD161, ␣␤TCR, ␥␦TCR, CD25, CD122, CD94, KIR3DL1, and the V␣24 and V␤11 TCR chains were determined by mAb staining and flow cytometry. Absolute numbers of lymphocyte subpopulations were calculated from the viable MNC counts. Changes in cell numbers over time in culture are expressed as ratios of the numbers of viable cells of a particular phenotype that were present after culture to the numbers of those cells that were present before culture (factorial changes in cell numbers).
Analysis of cell division
PBMC were either untreated or labeled before culture with CFSE as described by Lyons and Parish (40) . Cells were washed and suspended at a density of 5 ϫ 10 6 cells/ml in PBS containing 5 M CFSE for 10 min at 37°C, followed by washing with cold culture medium. The cells were then cultured in the absence or the presence of IL-2 or IL-15 as described above. Cells stimulated with 5 g/ml PHA and 25 ng/ml IL-2 were used as positive controls. Cell division of CFSE-labeled PBMC subpopulations was assessed by flow cytometry after labeling with CD3 and CD56.
Cytotoxicity assays
In vitro-expanded PBMC were separated into CD3
ϩ and CD3 Ϫ cell fractions using anti-CD3 mAb-coated magnetic beads (Miltenyi Biotec, Bergisch Gladbach, Germany) (33) . The purity of isolated fractions was assessed by flow cytometry, and preparations whose purities were Ͼ95% were used as effectors in cytotoxicity assays. NK cytotoxicity and lymphokine-activated killing (LAK) of K562 target cells by NK cells and CD56 ϩ T cells was assayed in 4-h 51 Cr release assays using the CD3 Ϫ cells and CD3 ϩ cells as effectors, respectively, at E:T ratios of 1:1 to 1:500. We and others have previously found that IL-2-induced LAK activity of human PBMC against K562 cells resides in CD56
ϩ , but not CD56 Ϫ , T cells (26, 33) ; therefore, the cytotoxic activity of NK cells and CD56 ϩ T cells was measured using the CD3 ϩ and CD3 Ϫ cell fractions, respectively.
Analysis of cytokine production
The effects of IL-2 and IL-15 on the production of IFN-␥, TNF-␣, IL-2, and IL-4 by stimulated peripheral blood NK cells, CD56 Ϫ T cells, and CD56 ϩ T cells was measured by a combination of cell surface and intracytoplasmic mAb staining and analysis by flow cytometry as described previously (33) . Briefly, human PBMC were cultured for 7 days in the absence or the presence of 25 ng/ml (50 U/ml) IL-2 or 10 ng/ml IL-15. The cells were then stimulated for 4 h with 10 ng/ml PMA plus 1 g/ml ionomycin or with plate-bound anti-CD3 mAb (10 g/ml HIT3a bound to plates by incubation for 6 h at 37°C in 0.1 M Na 2 HPO 4 ) in the presence of 1 ng/ml PMA and 10 g/ml brefeldin A. As controls, unstimulated cells were treated similarly. The cells were then stained with mAbs against cell surface CD3 and CD56, followed by fixing with 4% paraformaldehyde, permeabilizing with 0.2% saponin, and intracytoplasmic mAb staining for IFN-␥, TNF-␣, IL-2, or IL-4 (33) . Cytokine production by CD3 Ϫ CD56 ϩ NK and by CD3 ϩ CD56 Ϫ and CD3 ϩ CD56 ϩ T cells was detected by three-color flow cytometry.
Results
Lymphocyte subpopulations in human peripheral blood
Flow cytometry was used to determine the proportions of freshly isolated PBMC that expressed B cell (CD19
, and double-negative (DN) CD4 Ϫ
CD8
Ϫ phenotypes. The cell frequencies are shown in Table I . The frequencies of CD3 Ϫ and CD3 ϩ cells that expressed the NK cell markers CD16, CD161, CD56, CD158a, CD158b, KIR3DL1, and CD94 are shown in Table II 
Human NK and NKR ϩ T cells are selectively expanded by IL-2 and IL-15
Dose-and time-dependent expansion of NKR ϩ PBMC in response to culture with IL-15 and IL-2 added once at time zero, indicated that maximal changes in cell numbers occurred ϳ7 days after the addition of these cytokines. One to 10 ng/ml IL-15 ( Fig. 1A ) and 25 ng/ml IL-2 (data not shown) induced maximal expansion of cells expressing the NKRs, CD161, CD56, KIR3DL1, and CD94. Culturing of PBMC for 7 days in medium only, 25 ng/ml IL-2, or 10 ng/ml IL-15 resulted in mean 0.64-, 1.14-, and 1.26-fold changes in total lymphocyte numbers, respectively. The effects of culturing PBMC in the presence or the absence of 25 ng/ml IL-2 or 10 ng/ml IL-15 on the expansion of NK cells and T cells expressing different NKRs are compared in Fig. 1 
Human ␥␦ T cells and invariant ␣␤ T cells are selectively expanded by IL-2 and/or IL-15
The expansions of ␣␤ T cells, ␥␦ T cells, and T cells expressing the V␣24 and V␣24V␤11 TCRs that are associated with invariant V␣24J␣Q TCR ϩ cells (38, 41) were compared after culture in medium only or with 25 ng/ml IL-2 or 10 ng/ml IL-15. (Table III) , but IL-15 expanded them to Ͼ1%, and in one case 4%. Because ␥␦ TCRs are present on greater proportions of CD56 ϩ T cells than CD56 Ϫ T cells (Table III) , the effects of culturing PBMC in medium alone, IL-2, or IL-15 on ␣␤ and ␥␦ CD56 Ϫ and CD56 ϩ T cell expansions were compared. Fig.  2B shows that these cytokines induced only moderate proliferation of both ␣␤ and ␥␦ CD56 Ϫ T cells, but ␣␤ and ␥␦ CD56 ϩ T cells were significantly expanded by both IL-2 and IL-15. Thus, the expansions of ␥␦ T cells by these cytokines, shown in Fig. 2A , are mainly due to the expansion of CD56 ϩ T cells.
Expansions of CD8 ϩ and DN cells by IL-2 and IL-15 are due to NK cell and CD56
ϩ T cell expansions PBMC were cultured for 7 days in medium only or in 25 ng/ml IL-2 or 10 ng/ml IL-15 and changes in the numbers of cells expressing CD4, CD8, CD8␣ ϩ ␤ Ϫ , and DN and DP phenotypes were 
a All values are means of at least 4 and up to 15 samples.
determined. As shown in Fig. 3A , IL-2 and IL-15 induced a moderate (2-to 4-fold) expansion of CD8 ϩ cells, but CD4 ϩ cell numbers were not changed. As previously reported (20) Fig. 3, B-D ϩ T cell population (Fig. 3D) . Total CD4 ϩ cell expansions were not noted (Fig. 3A) , because all NK cells are negative for CD4, and only 8% of CD56 ϩ T cells are CD4 ϩ (Table III) . Similarly, NK and CD56 ϩ T cells bearing DN phenotypes were significantly expanded by IL-2 and IL-15, but because only 0.1% of CD56 Ϫ T cells are DN (Table III) , the overall increase in DN cells was only marginal. Thus, Fig. 3 indicates that the increases in the numbers of CD8
ϩ and DN cells in response to IL-2 and IL-15 reflect increases in NK cells and CD56 ϩ T cells, both populations that are predominantly CD8 ϩ or DN.
IL-2 and IL-15 induce proliferation of CD56 ϩ MNC
The expansions of CD56 ϩ cells in response to IL-2 or IL-15 appear to be due to the induction of both proliferation and survival, because cell numbers increased after culture with IL-2 or IL-15, but decreased after culture in medium alone (Figs. 1-3 ). To confirm that proliferation of CD56 ϩ cells takes place, PBMC were labeled with CFSE and cultured for 7 days in medium alone or in 25 ng/ml IL-2 or 10 ng/ml IL-15, and changes in the intensities of CFSE staining of CD56 ϩ and CD56 Ϫ cells were examined by flow cytometry. CFSE-labeled CD56 ϩ cells (Fig. 4D ), but not CD56 Ϫ cells (Fig. 4C) , underwent sequential halving of CFSE fluorescence intensity upon culture with IL-15. Similar results were obtained with PBMC cultured with IL-2 (data not shown). This halving of fluorescence intensity was comparable to, but less marked than, the profile seen with CD3 ϩ PBMC stimulated with PHA and cultured with IL-2 as a positive control (Fig. 4B) .
Expression of CD25 and CD122 by human peripheral blood CD56 Ϫ T cells, NK cells, and CD56 ϩ T cells
Flow cytometry revealed that the IL-2R ␣-chain, CD25, was expressed by a mean of 27% of freshly isolated human CD56 Ϫ T cells, but only by 2 and 7% of NK cells and CD56 ϩ T cells, respectively (Fig. 5A) . In contrast, the IL-2R/IL-15R ␤-chain, CD122, was constitutively expressed by NK cells (99%) and most CD56 ϩ T cells (74%), but only 10% of CD56 Ϫ T cells expressed this receptor (Table III and Fig. 5B ). All CD56 bright and most CD56 dim cells expressed CD122. Interestingly, the intensity of staining for CD122 was 10-fold higher on NK cells than on CD56 ϩ T cells (Fig. 5B) . Expression of the IL-15R ␣-chain or the common ␥-chain was not tested.
IL-2 and IL-15 induce spontaneous cytotoxicity by human peripheral NK cells and CD56
ϩ T cells PBMC were cultured for 7 days in medium only or in 25 ng/ml IL-2 or 10 ng/ml IL-15 and separated into CD3 Ϫ and CD3 ϩ fractions using mAb-coated magnetic beads. The purities of the isolated fractions were shown by flow cytometry to be Ͼ95% (data 
not shown). Isolated CD3
Ϫ and CD3 ϩ PBMC were used as effectors in cytotoxicity assays against K562 target cells. Fig. 6 shows that cytotoxic activity was present in CD3 Ϫ cells that were freshly isolated or cultured in medium alone, giving about 20% specific lysis at E:T ratios of 100:1. No cytotoxicity was detected in the CD3 ϩ fraction even at E:T ratios of 500:1. However, after incubation with either IL-2 or IL-15, both fractions demonstrated 55-75% specific lysis of K562 targets (Fig. 6 ). CD56 Ϫ T cells are incapable of killing K562 cells (26, 33) , so the cytotoxicity induced in the CD3 ϩ cells is attributable to the CD56 ϩ T cells. Therefore, CD56 ϩ T cells can be induced by either IL-2 or IL-15 to mature into LAK cells.
IL-2 and IL-15 do not induce cytokine production by resting human PBMC, but can augment cytokine production by activated PBMC
The effect of culturing PBMC for 7 days in medium only or in 25 ng/ml IL-2 or 10 ng/ml IL-15 on the production of IFN-␥, TNF-␣, IL-2, and IL-4 in the absence of stimulation or upon stimulation with PMA and ionomycin or anti-CD3 mAb was examined by intracellular cytokine staining and flow cytometry (Fig. 7A) . As shown in Fig. 7 (B and C) for IFN-␥ and IL-4, no cytokines were produced in the absence of stimulation even after culture with IL-2 or IL-15. However, compared with PBMC cultured in medium only and stimulated with either PMA and ionomycin or anti-CD3 mAb, the numbers of cells capable of producing IFN-␥ and IL-4 were dramatically increased by preculturing with IL-2 or IL-15 (Fig. 7, B and C) . Similar increases in TNF-␣-and IL-2-expressing PBMC were found in two experiments (data not shown).
IL-2 and IL-15 augment cytokine production by human PBMC by selectively expanding NK and CD56
ϩ T cells
The augmentation of cytokine production by IL-2 and IL-15 ( ϩ T cells expressing these cytokines (Fig. 8) . These results show that greater proportions of CD56 ϩ T cells produce IFN-␥ and IL-4 upon stimulation than NK and T cells, and that augmentation of cytokine production by IL-2 and IL-15 seen in Fig. 7 is due to selective expansion of CD56 ϩ T cells and, to a lesser degree, NK cells. Thus, IL-2 and IL-15 do not induce or costimulate cytokine production by PBMC, but they selectively expand IFN-␥-and IL-4-producing NK and CD56 ϩ T cells.
Discussion
Intracellular communications involved in immune responses are often mediated by cytokines that show a high degree of redundancy and pleiotropy. In this respect, IL-2 and IL-15 are structurally related cytokines that bind to receptors with shared signaling components and stimulate lymphocyte development, homing, proliferation, and survival (1-3). Differences in the cellular sites of synthesis and regulation of IL-2 and IL-15 production point to distinct roles for these cytokines in immune activation. IL-2 and IL-2R␣ appear only to be expressed by activated T cells, suggesting a role for this cytokine/receptor system in the perpetuation of adaptive immune responses. In contrast, IL-15 is produced by many cell types, including kidney, lung, heart, liver, placenta, skeletal muscle, epithelial cells, and monocytes, suggesting a broader role for this cytokine in innate immune responses and in the homeostatic maintenance of effector cells in various tissues (1, 4) . The multiplicity and selectivity of the stimulatory properties of IL-2 and IL-15 for different lymphocyte subpopulations prompted us to quantify the lymphocyte subpopulations present in human blood and to examine the effects of these cytokines on their proliferation, cytotoxic function, and cytokine secretion in vitro. We found that the effects of IL-2 and IL-15 on resting human lymphocyte subpopulations are essentially the same. Addition of either cytokine to human PBMC in the absence of prior activation resulted in selective expansions of NK cells and T cells expressing various NKRs (CD16, CD161, CD158a, CD158b, KIR3DL1, and CD94), but not of conventional T cells or B cells. CD56 ϩ T cells, which almost invariably coexpress one or another of these NKRs, were the most responsive, exhibiting 7-to 10-fold expansions in 1 wk. These expansions are due both to proliferation, because cell numbers increased, and cell division was observed as a sequential reduction of CFSE fluorescence, and to survival, because CD56 ϩ cells cultured in the absence of these cytokines were depleted. As reported previously (13, 42, 43) , only CD56 bright NK cells proliferated significantly in response to IL-2 or IL-15. CD56 bright cells are absent among fresh T cells, but both IL-2 and IL-15 up-regulated CD56 expression to levels comparable to those of CD56 bright NK cells. Although CD16 Ϫ NK cells are more responsive to low concentrations of IL-2 than CD16 ϩ NK cells (44), we found that both NK subsets responded similarly to 25 ng/ml IL-2 or 10 ng/ml IL-15.
Several studies have demonstrated that IL-15 preferentially promotes the survival and proliferation of ␥␦ over ␣␤ T cells (17) (18) (19) and CD8 ϩ over CD4 ϩ T cells (20, 45) , which has led Ma et al. (4) to suggest that ␥␦ and CD8 ϩ T cells resemble innate immune cells. These findings were confirmed in the present study, but we have further demonstrated that ␥␦ and CD8
ϩ T cell expansions in response to both IL-2 and IL-15 are due to expansions of CD56 ϩ T cells, of which 30 -50% express ␥␦ TCRs and 50 -80% express CD8. Both ␣␤ and ␥␦ T cells expressing CD56 were similarly expanded by IL-2 or IL-15, but conventional CD56 Ϫ T cells with either ␣␤ or ␥␦ TCRs were negligibly expanded. Similarly, proliferative responses of CD56 ϩ cells occurred regardless of CD4/ CD8/DN phenotypes, but minimal expansions of CD56 Ϫ T cells bearing CD4 ϩ , CD8 ϩ , or DN phenotypes were observed. CD8 ϩ and DN, but not CD4 ϩ , phenotypes are expressed by significant proportions of CD56 ϩ T cells and NK cells; therefore, expansions of CD4 ϩ cells are not detected when total MNC were examined. Thus, the previous data that indicate that ␥␦, CD8 ϩ , and DN lymphocytes proliferate in response to IL-15 (17) (18) (19) (20) 45 ) most likely reflect expansions of CD56 ϩ T cells and NK cells. Two lymphocyte subpopulations were found in the present study to proliferate differentially in response to IL-15 and IL-2. Lymphocytes expressing the CD8 ␣-chain in the absence of the CD8 ␤-chain, which are commonly found among intestinal IELs (18, 20) , and T cells expressing the V␣24V␤11 TCR, which would include invariant V␣24J␣Q ϩ NKT cells (36, 38, 41) , exhibited strong proliferative responses to IL-15, but not IL-2. ϩ T cell survival and proliferation, we further investigated whether these cytokines could activate these cells in cytotoxicity and cytokine production assays. Both CD56 dim and CD56 bright NK cells can spontaneously lyse a range of tumor cell lines in vitro (26 -28, 33) , and this cytotoxicity is enhanced by IL-2 and IL-15 (13, 43) . CD56 ϩ T cells can be induced to kill K562 targets by preincubation with IL-2 (LAK activity) (26 -28, 32, 33) . In the present study IL-15 had effects comparable to those of IL-2 in potently inducing cytotoxicity against K562 cells by both NK cells and CD56
ϩ T cells, but not by CD56 Ϫ T cells. Thus, IL-2 and Freshly isolated PBMC or PBMC that were cultured for 7 days in the absence or the presence of 25 ng/ml IL-2 or 10 ng/ml IL-15 were separated into CD3
Ϫ and CD3 ϩ fractions using mAb-coated magnetic beads and were used as effectors in chromium release assays at the indicated E:T ratios. Results are representative of four triplicate samples. (51, 52) . Our data indicate that neither IL-2 nor IL-15 induced the production of IFN-␥, TNF-␣, IL-4, or IL-2 by resting PBMC, but, as reported previously (53, 54), both cytokines augmented the production of all these cytokines in response to phorbol ester or anti-CD3 mAb stimulation. This augmentation was not the result of an induction of cytokine production by NK cells or T cells, but was due to proliferation of CD56 ϩ T cells subpopulations that most frequently responded to these stimuli. Thus, while Ͻ20% of T cells cultured in medium alone could produce IFN-␥ or IL-4 in response to phorbol ester stimulation or CD3 crosslinking, 50 -100% of NK cells and CD56 ϩ T cells in the same cultures produced IFN-␥ and/or IL-4. IL-2 or IL-15 did not enhance these proportions, but induced the survival and proliferation of the most "trigger-happy" effectors, NK cells and CD56 ϩ T cells. Neither IL-2 nor IL-15 polarized lymphocyte activation to Th1-or Th2-type responses via the selective stimulation of IFN-␥, TNF-␣, or IL-4 production. The combination of IL-2 and IL-15 has been reported to selectively induce IL-5 production by resting human NK cells (42) , and both cytokines can synergize with IL-12 and IL-18 in inducing IFN-␥ production (15, 44, 45, 55) . Therefore, IL-2 and IL-15 promote cytokine production by CD56 ϩ cells, but other factors are required to selectively activate Th1-or Th2-type responses.
The selective responsiveness of cells to various cytokines is governed by their expression of the appropriate receptors. As previously reported (43), we found that the majority of NK cells express the IL-2/15R ␤-chain, CD122, but not the IL-2R ␣-chain, IL-4 (right) . B and C, Absolute PBMC numbers producing IFN-␥ (B) and IL-4 (C) after incubating 100,000 PBMC for 7 days in medium only, 25 ng/ml IL-2, or 10 ng/ml IL-15 and stimulating for 4 h with 10 ng/ml PMA plus 1 g/ml ionomycin or with plate-bound anti-CD3 mAb. Cell numbers are expressed as products of the percentages of total PBMC expressing the cytokines and the total PBMC numbers. All results are the means of four experiments. CD25, suggesting that NK responses to IL-2 are mediated through a receptor complex consisting of CD122 and ␥c, which can participate in low affinity binding of IL-2 (3, 43) . All CD56 bright and most CD56 dim cells expressed CD122. We also found that CD25 expression by NK cells was induced by IL-2 (data not shown), confirming that both the low affinity IL-2R␤␥ and high affinity IL-2R␣␤␥ receptors can be used by NK cells (13, 43) . Similarly, CD56 ϩ T cells were found to express CD122, but not CD25, but, interestingly, NK cells expressed ϳ10-fold higher levels of CD122 than CD56 ϩ T cells, yet CD56 ϩ T cells proliferated more vigorously than NK cells in response to IL-2 or IL-15. The CD122/␥c receptor also mediates low affinity IL-15 signaling (13), thus explaining the similarities of NK and CD56 ϩ T cell responses to both IL-2 and IL-15. Resting CD56 Ϫ T cells are negative for CD122 and do not respond to these cytokines. mAbs specific for IL-15R␣ were not available for analysis of the expression of this receptor chain, but previous studies have shown that IL-15R␣ is expressed by several nonlymphoid and lymphoid cell types, and IL-15R␣ mRNA expression by lymphocytes can be up-regulated by activation (56) .
Although IL-2 and IL-15 differ in their cellular sites of synthesis (1-3) and have distinct roles in lymphocyte development (6 -11), we have found that these cytokines have almost identical effects on resting lymphocyte proliferation, cytotoxicity, and cytokine secretion. IL-15 is produced by several nonlymphoid cell types and is likely to contribute to the initiation of innate immune responses via the partial activation of NK cells, which, in turn, regulate T cell differentiation into Th1 or Th2 cells. IL-2 is produced by activated T cells in the adaptive immune response and induces the proliferation of IL-2R-positive activated T cells, thus amplifying the response until a point at which IL-2 induces apoptosis. The partial activation of NK cells by IL-2 indicates that it also influences innate immune responses, and this feedback mechanism may serve to enhance or substitute for the first-line defense mechanisms involving IL-15-secreting cells. CD56 ϩ T cells also display properties of innate lymphocytes, having invariant receptors for stimulatory ligands present on target cells (24, 35, 37, 41) and the capacity to rapidly kill tumor cells (26 -31, 33, 34) , to produce cytokines (22, 24, 33, 37, 38) , and to respond to IL-12 (34) . Alternatively, CD56 ϩ T cells may constitute a subset of memory cells. They express activated/ memory CD45RA
CD69
ϩ phenotypes (22, 32) and homing chemokine receptors (39) . They have a predominant localization in peripheral tissues (24, 32, 33) and can rapidly acquire effector functions (22, 26 -31, 33, 34) . A role for IL-15 in inducing proliferation of memory CD8 ϩ T cells has previously been reported (1, 10, 12) and CD56 has been reported to be expressed by most IL-2-dependent Ag-specific CTL lines in long term culture (28) . T cell expression of other NKRs, including KIRs and CD94, can be induced by activation (48, 49) , and KIR and CD94 induction correlates with the transition from effector to memory CTLs (30, 57) . Therefore, IL-2 and IL-15 appear to have roles in immune activation at the innate, adaptive, and memory stages of an immune response.
